Norfloxacin ophthalmic Alternatives Compared
Norfloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
---|
Norfloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
---|---|---|---|
Prescription only
Prescribed for Conjunctivitis. Norfloxacin ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Iritis, Cyclitis, Keratitis, Conjunctivitis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Lotemax may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Conjunctivitis, Eye Conditions, Trachoma. Sulfacetamide sodium ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions |
More about Lotemax (loteprednol) | More about Sulfacetamide sodium ophthalmic | ||
Ratings & Reviews | |||
Be the first to share your experience with this drug. |
Lotemax has an average rating of 6.6 out of 10 from a total of 18 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 33% reported a negative effect. |
Sulfacetamide sodium ophthalmic has an average rating of 8.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
View all Norfloxacin ophthalmic side effects |
View all Lotemax side effects |
||
Drug Class | |||
Generic Availability | |||
N/A |
Lower cost generic |
||
Pricing and Coupons * Prices are without insurance | |||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | |||
N/A |
|
|
|
Brand Names | |||
N/A |
Other loteprednol brands include: Alrex, Eysuvis, Inveltys, Lotemax SM | AK-Sulf, Bleph-10, Cetamide | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
N/A |
N/A |
N/A |
|
CSA Schedule 1 View glossary of CSA terms | |||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | |||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
Drug Interactions | |||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 42 drugs are known to interact with Lotemax:
|
A total of 1 drugs are known to interact with Sulfacetamide sodium ophthalmic:
|
|
Alcohol/Food/Lifestyle Interactions | |||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | |||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||
First Approval Date | |||
N/A |
April 15, 2011 |
July 21, 1946 |
|
WADA Class View classifications | |||
N/A |
N/A |
N/A |
|
More Information | |||
Patient Resources | |||
N/A |
|||
Professional Resources | |||
N/A |
|||
Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.